Clomiphene citrate increases insulin-like growth factor binding protein-1 and reduces insulin-like growth factor-I without correcting insulin resistance associated with polycystic ovarian syndrome

Human Reproduction

Volumn 15, Issue 11, 2000, Pages 2302-2305

  De Leo, Vincenzo ^a   Marca, Antonio La ^a   Morgante, Giuseppe ^a   Ciotta, Liliana ^b   Mencaglia, Luca ^c   Cianci, Antonio ^b   Petraglia, Felice ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c Liasion Committee Florence Office   (Italy)

Author keywords

Clomiphene; IGF I; IGFBP 1; Insulin; PCOS

Indexed keywords

CLOMIFENE CITRATE; ESTRADIOL; FOLLITROPIN; GLUCOSE; HYDROXYPROGESTERONE; INSULIN; LUTEINIZING HORMONE; MEDROXYPROGESTERONE ACETATE; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN C; TESTOSTERONE;

ADULT; AMENORRHEA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE ASSOCIATION; DRUG EFFECT; DRUG MECHANISM; FEMALE; FEMALE INFERTILITY; HORMONE BLOOD LEVEL; HUMAN; HYPERANDROGENISM; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; OLIGOMENORRHEA; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PROTEIN BLOOD LEVEL; TREATMENT OUTCOME;

FALLOPIA;

EID: 0033758184     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/15.11.2302     Document Type: Article

References (33)

1. Clomiphene citrate: Mechanism(s) and site(s) of action - A hypothesis revisited
2. Insulin stimulates androgens accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism
3. Regulation of androgen production in cultured human thecal cells by insulin-like growth factor I and insulin
4. Clinical uses of insulin-like growth factor I
5. Clomiphene citrate reduces serum insulin-like growth factor I and increases sex hormone-binding globulin levels in women with polycystic ovary syndrome
6. Insulin-like growth factor-I and insulin potentiate luteinizing hormone-induced androgen synthesis by rat ovarian thecal-interstitial cells
7. Insulin regulation of insulin-like growth factor-binding protein production in cultured Hep G2 cells
8. Effects of metformin on gonadotropin-induced ovulation in women with polycystic ovary syndrome
9. Effect of metformin on insulin growth factor I and insulin growth factor binding protein I in polycystic ovary syndrome
10. Measurement of insulin resistance in vivo
11. Insulin-like growth factor-I and follicle-stimulating hormone suppress insulin-like growth factor binding protein-I secretion by human granulosa-luteal cells
12. Insulin-like growth factor I (IGF-I) regulates aromatase activity in human granulosa and granulosa luteal cells
13. The effects of insulin and insulin-like growth factors-I and -II on estradiol production by granulosa cells of polycystic ovaries
14. Aromatase activity in human granulosa cells during follicular development and the modulation by FSH and insulin
15. The role of insulin-like growth factor-I (IGF-I) and IGF binding protein-I (IGFBP-I) in the pathogenesis of polycystic ovary syndrome
16. Determination of insulin and insulin-like growth factors in the ovarian circulation
17. The potential relevance of growth hormone to female reproductive physiology and pathophysiology
18. Placental protein 12 is a decidual protein that binds somatomedin and has an identical N-terminal amino acid sequence with somatomedin-binding protein from human amniotic fluid
19. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome
20. Treatment of severe insulin resistance
21. Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome
22. Substituted amino-alkoxytriarylhaloethylenes
23. 14C] clomid (MRL-41) in various organs of the immature female guinea pig
24. Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein
25. Low levels of low molecular weight insulin-like growth factor-binding protein in patients with polycystic ovarian disease
26. Oral contraceptives increase insulin-like growth factor binding protein-I concentration in women with polycystic ovarian disease
27. Differential regulation of insulin-like growth factor binding protein secretion from human decidual cells by IGF-I, insulin and relaxin
28. Serum levels of insulin-like growth factor binding protein-1 and ovulatory responses to clomiphene citrate in women with polycystic ovarian disease
29. Serum and follicular fluid levels of insulin-like growth factor I (IGF-I), IGF-II, and IGF-binding protein-1 and -3 during the normal menstrual cycle
30. Elevated serum levels of free insulin-like growth factor I in polycystic ovary syndrome
31. Menstrual cyclicity after metformin therapy in polycystic ovary syndrome